Vulnerability   
Search   
    Search 324607 CVE descriptions
and 145615 test descriptions,
access 10,000+ cross references.
Tests   CVE   All  

Test ID:1.3.6.1.4.1.25623.1.0.821145
Category:General
Title:Mozilla Firefox ESR Security Advisory (MFSA2022-11) - Windows
Summary:Mozilla Firefox ESR is prone to multiple; vulnerabilities.
Description:Summary:
Mozilla Firefox ESR is prone to multiple
vulnerabilities.

Vulnerability Insight:
Multiple flaws exist due to,

- Browser window spoof using fullscreen mode.

- iframe allow-scripts sandbox bypass.

- Time-of-check time-of-use bug when verifying add-on signatures.

- Use-after-free in text reflows.

- Temporary files downloaded to /tmp and accessible by other local users.

Vulnerability Impact:
Successful exploitation will allow
attackers to run arbitrary code, bypass security restrictions, conduct spoofing
and cause a denial of service on affected system.

Affected Software/OS:
Mozilla Firefox ESR version before
91.7 on Windows.

Solution:
Upgrade to Mozilla Firefox ESR version 91.7
or later, Please see the references for more information.

CVSS Score:
10.0

CVSS Vector:
AV:N/AC:L/Au:N/C:C/I:C/A:C

Cross-Ref: Common Vulnerability Exposure (CVE) ID: CVE-2022-26383
https://bugzilla.mozilla.org/show_bug.cgi?id=1742421
https://www.mozilla.org/security/advisories/mfsa2022-10/
https://www.mozilla.org/security/advisories/mfsa2022-11/
https://www.mozilla.org/security/advisories/mfsa2022-12/
Common Vulnerability Exposure (CVE) ID: CVE-2022-26384
https://bugzilla.mozilla.org/show_bug.cgi?id=1744352
Common Vulnerability Exposure (CVE) ID: CVE-2022-26387
https://bugzilla.mozilla.org/show_bug.cgi?id=1752979
Common Vulnerability Exposure (CVE) ID: CVE-2022-26381
https://bugzilla.mozilla.org/show_bug.cgi?id=1736243
CopyrightCopyright (C) 2022 Greenbone AG

This is only one of 145615 vulnerability tests in our test suite. Find out more about running a complete security audit.

To run a free test of this vulnerability against your system, register below.




© 1998-2025 E-Soft Inc. All rights reserved.